Global Patent Index - EP 1067961 A2

EP 1067961 A2 2001-01-17 - LEISHMANIA CYSTEINE PROTEINASES

Title (en)

LEISHMANIA CYSTEINE PROTEINASES

Title (de)

LEISHMANIA CYSTEIN-PROTEINASE

Title (fr)

CYSTEINE-PROTEINASES DE LEISHMANIES

Publication

EP 1067961 A2 (EN)

Application

EP 99915864 A

Priority

  • GB 9900889 W
  • GB 9807293 A

Abstract (en)

[origin: WO9951264A2] The present invention relates to a Leishmania vaccine, more particularly a Leishmania vaccine comprising active or inactive cysteine proteinase(s), particularly in recombinant form, for use in immunising mammals, such as dogs and/or humans.

IPC 1-7 (main, further and additional classification)

A61K 39/008; C07K 14/44; C12N 15/30

IPC 8 full level (invention and additional information)

A61K 39/008 (2006.01); A61P 33/02 (2006.01); C07K 14/44 (2006.01); C12N 9/64 (2006.01); C12N 15/30 (2006.01); A61K 39/00 (2006.01)

CPC (invention and additional information)

C12N 9/6472 (2013.01); A61K 39/008 (2013.01); C07K 14/44 (2013.01); A61K 39/00 (2013.01)

Citation (search report)

See references of WO 9951264A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9951264 A2 19991014; WO 9951264 A3 19991209; AP 200001945 D0 20001231; BR 9909388 A 20001205; EP 1067961 A2 20010117; GB 9807293 D0 19980603; IL 138639 D0 20011031

INPADOC legal status


2008-05-07 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20071031

2004-04-14 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20040301

2001-01-17 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20001102

2001-01-17 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE